United States · Series B startup

Who invested in Chondrial Therapeutics

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$27Mraised across 2 rounds since 2014, from 2 sources

$1.0MDebt$26MSeries B
Latest round
Series B, $26MMay 2019
Step-upi
25.8×
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201420152016201720182019
$1.0MDebt$26MSeries B
First round
Debt, $1.0M
Mar 2014
Biggest round
$26M
Series B · May 2019
Between rounds
5.2 years
from the last two

The rounds

  1. May 2019
    Series B$26M2 new

    Reported by PhillySEC filing: $26M sold, first sale Nov 2016

  2. Mar 2014
    Debt$1.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $1.0M sold, first sale Mar 2014

Founders and team

From the SEC filings it signed: 2 on the team.

  • Ronald Mark PayneExecutive Officer, Directori
  • Steven Reed PlumpExecutive Officeri

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Debt2014Series B2019LD CapitalDeerfield

Everyone who backed them

LD CapitalVC firm1round
DeerfieldVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Chondrial Therapeutics

Who invested in Chondrial Therapeutics?

Chondrial Therapeutics's investors include LD Capital and Deerfield.

How much has Chondrial Therapeutics raised?

Chondrial Therapeutics has raised $27M across 2 rounds since 2014.

When did Chondrial Therapeutics last raise?

Chondrial Therapeutics's most recent round was a Series B of $26M in May 2019.

What was Chondrial Therapeutics's biggest round?

Its most recent round, $26M in May 2019, is also its largest on record.

Who backed Chondrial Therapeutics first?

Chondrial Therapeutics's first round on record, in May 2019, was backed by LD Capital and Deerfield.

What stage is Chondrial Therapeutics at?

Chondrial Therapeutics's latest named round is a Series B, in May 2019.

Where is Chondrial Therapeutics based?

Chondrial Therapeutics is based in the United States.

Companies like Chondrial Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.